Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II
Glenn Hartelius, Sherry-Anne Muscat, Lucie Bartova
Frontiers in Psychiatry August 30, 2024 DOI: 10.3389/fpsyt.2024.1471609 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Esketamine Ketamine |
Abstract
protocols are designed to integrate and harness the full range of ketamine's intrinsic properties, ketamine therapies can realize their full potentials [3], possibly leading to improved outcomes in broader patient populations. Our first paper, "The Montreal model: An integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression," takes this path toward optimizing the use of ketamine's unique potentials.
Citations in the library
Cites 3
- An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression. Frontiers in Psychiatry November 24, 2021
- Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders Frontiers in Psychiatry August 14, 2023
- Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology January 2024